Approval · Notice of Compliance 2708 · 1998
BEZALIP: Notice of Compliance 2708
Issued November 3, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2708
- Date
- November 3, 1998
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revised product monograph
- Therapeutic class
- Lipid metabolism regulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BEZALIP | Not yet assigned | — |
Medicinal ingredients
- BEZAFIBRATE 200 MG per TAB
- BEZAFIBRATE 400 MG per TAB